Viewing Study NCT00768105


Ignite Creation Date: 2025-12-25 @ 3:15 AM
Ignite Modification Date: 2025-12-30 @ 6:30 AM
Study NCT ID: NCT00768105
Status: COMPLETED
Last Update Posted: 2010-12-03
First Post: 2008-10-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module